Safe and stable retroviral helper cell line and related compositions and methods
AssigneeGenecure LLP
InventorFrank Yao Tsung Tung
Life of this patent
Estimating the term…
Loading patent…
AssigneeGenecure LLP
InventorFrank Yao Tsung Tung
Estimating the term…
A safe gene transfer system is provided based on simian immunodeficiency virus (SIV). A packaging construct is provided in which the SIV packaging sequence is removed, and, in one instance, the gag, pol and other accessory genes are expressed under the control of CMV promoter. SIV transfer constructs are provided in which cis-acting sequences required for viral replication (R, tRNA primer binding site, encapsidation site, RRE sequence and 3′ LTR), with or without a marker gene, are described. Stable packaging cell lines are provided that were prepared by transfecting 293(T) cells with an SIV packaging construct. High titer virus (>107 transducing units/ml) can be produced upon transient transfection with SIV transfer vectors. The safety of the described SIV gene transfer vectors was further tested in a primate model. Rhesus monkeys that received multiple inoculations of high titer (107) retroviral vectors did not develop any signs of side effects.
A method of producing retroviral particles by transfecting with an SIV transfer vector an SIV packaging cell line comprising a nucleic acid comprising an SIV 5′ splice donor site 5′ to SIV gag and pol genes, wherein the packaging sequence between the 5′ splice donor site and the initiation site of the gag gene is removed.
An isolated nucleic acid for use in producing a SIV packaging cell line comprising an SIV 5′ splice donor site 5′ to SIV gag and pol genes, or derivatives thereof, wherein the packaging sequence between the 5′ splice donor site and the initiation site of the gag gene is removed.
An isolated and purified nucleic acid consisting of one of plasmid pSP, or a derivative thereof.
An isolated and purified nucleic acid consisting of one of plasmid pCMV239 ψ−, or a derivative thereof.
An SIV transfer vector, comprising:
A method for testing for replication-competent SIV virus or recombinant versions thereof, comprising the steps of:
A method for testing for replication-competent SIV virus or recombinant versions thereof, comprising the steps of:
Dependencies are inferred from the claim text.